The genomic sequences of many hepatitis C virus (HCV) isolates have been reported and a variety of virus genotypes have been classified based on homology in the conserved regions. We have previously identified five distinct genotypes (la, lb, 2a, 2b and 3b) in Japanese palients with chronic HCV infection by comparing the sequences of the NS5 region. The complete nucleotide sequence for five genotypes (la, lb, lc, 2a and 2b) have already been reported and we report here the complete nucleotide sequence of genotype 3b. The isolate (HCV Tr) was 9439 nucleotides long, excluding the poly(U) tract at its 3' end, and encodes a single long open reading frame of 3023 amino acids. Total nucleotide sequence homologies were 68.4 to 68.7 %, 68"3 to 69.0 %, 67.2 %, 65.8 % and 65-6 % compared with type la, lb, lc, 2a and 2b genomes, respectively. The amino acid sequences of these five genotypes were highly homologous in the core, NS3 and NS5B regions, but the E2/NS1 region, which contains hypervariable regions 1 and 2, and the NS5A region were poorly conserved. Although it was possible to detect antibody against the relatively homologous core and NS3 regions by ELISA, the presence of divergent protein structures must be taken into account in the development of a vaccine.
The genomic sequences of many hepatitis C virus (HCV) isolates have been reported and a variety of virus genotypes have been classified based on homology in the conserved regions. We have previously identified five distinct genotypes (la, lb, 2a, 2b and 3b) in Japanese palients with chronic HCV infection by comparing the sequences of the NS5 region. The complete nucleotide sequence for five genotypes (la, lb, lc, 2a and 2b) have already been reported and we report here the complete nucleotide sequence of genotype 3b. The isolate (HCV Tr) was 9439 nucleotides long, excluding the poly(U) tract at its 3' end, and encodes a single long open reading frame of 3023 amino acids. Total nucleotide sequence homologies were 68.4 to 68.7 %, 68"3 to 69.0 %, 67.2 %, 65.8 % and 65-6 % compared with type la, lb, lc, 2a and 2b genomes, respectively. The amino acid sequences of these five genotypes were highly homologous in the core, NS3 and NS5B regions, but the E2/NS1 region, which contains hypervariable regions 1 and 2, and the NS5A region were poorly conserved. Although it was possible to detect antibody against the relatively homologous core and NS3 regions by ELISA, the presence of divergent protein structures must be taken into account in the development of a vaccine.
Hepatitis C virus (HCV), a positive-stranded RNA virus responsible for the majority of post-transfusion non-A, non-B hepatitis cases, was first identified only a few years ago (Choo et al., 1989) . Enomoto et al. (1990) identified four subtypes (Pt, K1, K2a and K2b) in Japanese patients by comparing the nucleotide sequences of their NS5 regions. Okamoto et al. (1991 Okamoto et al. ( , 1992a determined the entire nucleotide sequence of four isolates (I, II, III and IV), which correspond to Pt, K1, K2a and K2b, respectively. Also, Mori et al. (1992) identified another two genotypes and classified them as types V and VI. Simmonds et al. (1993) analysed nucleotide sequences of the NS5 region and proposed a new classification scheme for HCV genotypes including six major genotypes (l to 6) and 11 distinct subtypes. In this system, genotypes I, II, III, IV, V and VI correspond to Simmonds' types la, lb, 2a, 2b, 3a and 3b, respectively. Similarly, Bukh et al. (1993) identified at least 12 distinct genotypes after
The nucleotide sequence and related data reported in this paper will appear in the GSDB, DDBJ, EMBL and NCBI databases with the following accession numbers: D26556 (full nucleotide sequence of isolate HCV Tr), D11443 (5" non-coding region, core, El and part of E2/NSI region of isolate HPCENCR) and D10585 (NS5 region of clone pMHCI01).
analysing nucleotide sequences of the putative E1 region. Recently, Simmonds et al. (1994a) performed phylogenetic analyses of the core, E1 and NS5 regions and showed that such subgenomic regions contain sufficient phylogenetic information for the identification of each of the 11 or 12 types and subtypes of HCV. A new, comprehensive nomenclature system has been proposed by researchers in this field (Simmonds et al., 1994b) . At least 17 complete nucleotide sequences of genotypes l a, lb, lc, 2a and 2b have been reported to date (Kato et al., 1990; Choo et al., 1991 ; Han et al., 1991 ; Okamoto et al., 1991 Okamoto et al., , 1992a Okamoto et al., , b,c, 1994 Takamizawa et al., 1991; Inchauspe et al., 1991 ; Tanaka et al., 1992; Honda et al., 1992; Chen et al., 1992 ; Hayashi et al., 1993 ; Wang et al., 1993 ; S.-I. Bi and coworkers, and J.M. Cho and coworkers, unpublished results, GenBank accession numbers M96362 and L02836, respectively). We previously identified a new genotype from three Japanese patients with chronic hepatitis C and developed a PCR method that enabled quick determination of these five major genotypes (Chayama et al., 1993) . This new genotype, which we arbitrarily named Tr, showed high nucleotide sequence similarity (90-0 to 92-0 %) with HCV sequences isolated from patients in Thailand (Mori et al., 1992) that were classified as type 3b by Simmonds et al. (1993) . In the current study, we determined the complete 
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HC-J8(21) 2B-1(5) EG-7(4) EG -13 (4) EG - Primers from several well conserved regions of other HCV genotypes were used to amplify HCV cDNA by PCR, but a significant portion could not be amplified because of poor nucleotide sequence homology. We determined the nucleotide sequences of the missing portions and the 5' and 3' ends (Frohman et al., 1988 ). The PCR products were then cloned into M13 phage vectors and the nucleotide sequences were determined by the dideoxynucleotide chain termination method (Sanger et al., 1977) . The entire genomic sequence of isolate Tr was amplified as 21 overlapping segments using the primers listed in Table l . To eliminate misincorporation by Taq DNA polymerase, at least three clones were sequenced for each segment. The 5' and 3' ends were analysed in 10 and eight clones, respectively. Fig. 1 . Phylogenetic tree of HCV isolates based on nucleotide sequences (nucleotides 8350 to 8571) of the NS5B region. The total number of synonymous and non-synonymous substitutions among the nucleotide sequences were estimated by the method of Gojobori et al. (1982) . Using these numbers, a phylogenetic tree was constructed by the neighbour-joining method (Saitou & Nei, 1987) . References: (1), Okamoto et al., 1993 ; (2) , Mori et al., 1992 ; (3) , Tokita et al., 1994; (4) , Simmonds et al., 1993; (5) , Chayama et al., 1993; (6) , Okamoto et al., 1992a ; (7), Choo et al., 1991; (8), lnchauspe et al., 1991 ; (9) , Honda et al., 1992; (10), Okamoto etal., 1992b; (11) , Kato et al., 1990; (12) , Wang et aL, 1993; (13) , S.-I. Bi and coworkers, unpublished results; (14), Chen et al., 1992; (15) , Tanaka et aL, 1992; (16) , Cha et al., 1992; (17) , Takamizawa et al., 1991; (18) , Hayashi et al., 1993; (19) , Okamoto et al., 1994; (20) , Okamoto et al., 1991 ; (21) , Okamoto et al., 1992c . (Han et al., 1991 ; Inchauspe et al., 1991 ; Okamoto et al., 1992a) , nine for type lb (Kato et al., 1990; Choo et al., 1991 ; Han et al., 1991 ; Takamizawa et al., 1991 ; Inchauspe et al., 1991 ; Okamoto et al., 1992a, b; Tanaka et al., 1992; Honda et al., 1992; Chen et al., 1992; Hayashi et al., 1993 ; S.-I. Bi and coworkers, and J.-M. Cho and coworkers, unpublished results), one for type lc, one for type 2a (Okamoto et al., 1991) and one for type 2b (Okamoto et al., 1992c) were analysed. HCV Tr was found to be 9439 nucleotides long, excluding the poly(U) tract at its 3' end, and encoded a single long open reading frame (ORF) of 3023 amino acids, Based on a comparison of the nucleotide sequences of the NS5 region and phylogenetic analysis, the Tr genotype was confirmed as type 3b (Fig. 1) . The total and partial nucleotide and amino acid sequence homologies were compared with other genotypes and the results are shown in Table 2 . A comparison of nucleotide sequence of HCV Tr with partial nucleotide sequences are shown in Table 3 .
The 5' non-coding region (5' NCR) of the genome was located 339 nucleotides upstream from the initiation codon for the ORF. Although a comparison with other genotypes showed significant nucleotide sequence diversity within the 15 nucleotides at the 5' end (Fig. 2) , the secondary structures predicted by computer analysis were similar (data not shown). Okamoto et al. (1991) postulated that the length of the 5' NCR of the HCV genome is 341 nucleotides and this is consistent with a number of Y-terminal sequences available in nucleotide databases. Our results also showed that all isolates of genotype la, lb, 2a and 2b, except for isolate 2a 2 (Fig.  2) , which showed one nucleotide deletion at one of five successive C residues at nucleotides 5 to 9, have a 5' NCR of 341 nucleotides. Since two genotype 3b isolates were cloned and sequenced in parallel with these 10 isolates, we believe that the 5' NCR of genotype 3b has 339 nucleotides. The similar secondary structures seen across all five genotypes, including the one isolate that was one nucleotide shorter (isolate 2a2), suggests that this structure may be important in HCV replication or Fig. 3 . Comparison of amino acid sequences among five major genotypes in the E2/NS1 and NS5 regions, where clustering of amino acid insertions and deletions were seen. Amino acid sequences were poorly conserved in these areas. (a) The two reported HVR domains (overlined) are contained within the putative E2/NSI region (Hijikata et al., 1991) . The shaded box represents a poorly conserved domain among genotypes. (b) Another poorly conserved domain, seen in the putative NS5A region, again indicated by the shaded box. There are multiple amino acid insertions and deletions in these areas.
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translation. The 3' NCR region of the type 3b isolate, excluding the poly(U) tract, was 31 nucleotides in length; it was shorter than those of genotypes la, lb, 2a and 2b, but longer than that of type 3a, which is reported to be only 23 nucleotides long . The stop codon for the viral polyprotein was TGA and there was no additional in-frame stop codon, as recently reported for type 3a by Okamoto et al. (1993) . The three hairpin structure predicted by Han et al. (1991) was also predicted with genotype 3b. The structure and spacing (59 to 61 bases) were quite similar in each genotype, suggesting that this structure is functionally important for viral replication. The third stem and loop structure was also present but its size varied slightly among the genotypes. The fourth hairpin structure identified in genotype 1 and 2 isolates (Han et al., 1991) was absent. Thus, the second in-frame stop codon and fourth hairpin structure might be less functionally important. Amino acid sequence comparisons among genotypes la, lb, 2a, 2b, 3a and 3b revealed conserved and divergent areas ( Table 2 ). The most highly conserved region among these genotypes was the core region, although the NS3 and NS5B regions were also relatively conserved. In contrast, the NS5A region, which contained clusters of amino acid insertions and/or deletions, was poorly conserved. Clustering was also present in hypervariable region (HVR) 2 within the E2/NS1 region (Hijikata et al., 1991) and about 90 amino acids downstream, resulting in very poorly conserved parts within E2/NS1. Although amino acid sequence homologies were significantly lower among the different genotypes in the E2/NS1 region and in part of the NS5A region (Fig. 3 a, b ), they were relatively conserved among isolates of the same genotype.
As shown in Table 2 , isolates of different genotypes showed significant overall amino acid sequence diversity, suggesting that they may have different biological properties. One such difference that has been observed clinically is resistance to interferon therapy. Genotype lb is resistant to interferon treatment, whereas genotypes 2a and 2b are sensitive to it (Yoshioka et al., 1992; Tsubota et al., 1994) . The effect of interferon on genotype 3b has not yet been reported. Only three patients with genotype 3 HCV infection (3a or 3b not specified) have been reported to have undergone treatment with interferon and two of them responded . Although two of three Japanese patients with genotype 3b HCV infection treated with interferon responded well to the therapy (K. Chayama & H. Kumada, unpublished results) , further studies are needed to determine the sensitivity of this genotype to interferon. While it is difficult to determine which viral structure(s) is responsible for such different responses to interferon therapy, comparison of the amino acid sequences and functional analysis of viral proteins, such as helicase, protease and polymerase, as well as the functions of the 3' and 5' NCRs, are necessary to identify the mechanism.
It must be remembered that the ultimate goal is to develop a vaccine against HCV. It is therefore important to determine the infectious route of this virus, and the analysis of the entire genome of all genotypes is critical to understand the biological and pathological properties of HCV. Although the best target epitope for virusneutralizing antibody has not been identified, antibody against the E2/NS1 region, which presumably codes for surface glycoprotein, has been developed and the disappearance of the virus population with the corresponding amino acid sequences has been reported (Weiner et al., 1992; Taniguchi et al., 1993) . Thus, although this region has been suggested to be a good target for vaccine, the different structure and the high degree of variability of this region found in the present type 3b isolate suggests that it is not useful for protection against all genotypes. Furthermore, reinfection reportedly occurred in chimpanzees by repeated injection of innocula with a different nucleotide sequence in the E2/NS1 region (Farci et al., 1992) . More information on nucleotide sequence variability, secondary structure of the viral RNA and the tertiary structure of the translation products is necessary to determine the best target for virus neutralization.
